- D68.311 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D68.311 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D68.311 – other international versions of ICD-10 D68.311 may differ.
ICD-10-CM D68.311 is grouped within Diagnostic Related Group(s):
- 813 Coagulation disorders
Applicable To
- Autoimmune hemophilia
- Autoimmune inhibitors to clotting factors
- Secondary hemophilia
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D68.311:
- inhibitors to clotting factors > Autoimmune
- acquired > Hemophilia (classical) (familial) (hereditary) D66
- autoimmune > Hemophilia (classical) (familial) (hereditary) D66
- secondary > Hemophilia (classical) (familial) (hereditary) D66